LGG-44. CLINICAL AND MOLECULAR TUMOR CHARACTERISTICS OF ‘HIGHER RISK’ PEDIATRIC LOW-GRADE GLIOMAS
T Rijsdijk(Princess Máxima Center), Mariëtte E.G. Kranendonk(Princess Máxima Center), Eelco W. Hoving(Princess Máxima Center), Pieter Wesseling(Radboud University Nijmegen), Lennart Kester(Royal Netherlands Academy of Arts and Sciences), Jasper van der Lugt(Princess Máxima Center), Julie A S Lammers(Princess Máxima Center), Netteke A Y Schouten- van Meeteren(Princess Máxima Center), Raoll Hoogendijk(Princess Máxima Center), Bastiaan B.J. Tops(Radboud University Nijmegen), Karina J. Kersbergen(Princess Máxima Center), Lisethe Meijer(Princess Máxima Center)
Cited by 0
Related Papers
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
<scp>WHO</scp> 2016 Classification of gliomas
|Neuropathology and Applied Neurobiology|2017|817
Diffuse glioma growth: a guerilla war
|Acta Neuropathologica|2007|640